Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart Disease
- 15 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 115 (19) , 2533-2539
- https://doi.org/10.1161/circulationaha.106.682450
Abstract
Background— Fetuin-A is a multifunctional hepatic secretory protein that inhibits dystrophic vascular and valvular calcification. Lower serum fetuin-A concentrations are associated with valvular calcification in persons with end-stage renal disease. Whether fetuin-A is associated with valvular calcification in other patient populations is unknown. Methods and Results— We evaluated the associations among serum fetuin-A concentrations, mitral annular calcification, and aortic stenosis in 970 ambulatory persons with coronary heart disease and without severe kidney disease. The presence or absence of mitral annular calcification and aortic stenosis was determined by transthoracic echocardiography. The subjects’ mean age was 66 years; 81% were men; 189 (20%) had mitral annular calcification; and 79 (8%) had aortic stenosis. Participants were categorized by tertiles of fetuin-A concentrations. Those within the highest fetuin-A tertile had significantly lower odds of mitral annular calcification compared with the lowest tertile (adjusted odds ratio, 0.47; 95% confidence interval, 0.29 to 0.77; P =0.002); this association was similar regardless of diabetes status ( P for interaction=0.34). In contrast, the association of fetuin-A with aortic stenosis was modified by the presence or absence of diabetes mellitus ( P for interaction=0.03). Among participants without diabetes, the highest fetuin-A tertile had a significantly lower odds of aortic stenosis compared with the lowest tertile (adjusted odds ratio, 0.37; 95% confidence interval, 0.15 to 0.92; P =0.03), whereas among participants with diabetes, no statistically significant association was observed between fetuin-A and aortic stenosis (adjusted odds ratio, 1.49; 95% confidence interval, 0.48 to 4.63; P =0.49). Conclusions— Among persons with coronary heart disease, we observed an inverse association of fetuin-A and mitral annular calcification. An inverse association also was observed between fetuin-A and aortic stenosis among participants without diabetes mellitus. Fetuin-A may represent an important inhibitor of dystrophic calcification in persons with coronary heart disease.Keywords
This publication has 37 references indexed in Scilit:
- Calcification and Cardiovascular HealthHypertension, 2006
- Fetuin-A and kidney function in persons with coronary artery disease—data from the heart and soul studyNephrology Dialysis Transplantation, 2006
- Clinical significance of calcification of the fibrous skeleton of the heart and aortosclerosis in community dwelling elderly. The Cardiovascular Health Study (CHS)American Heart Journal, 2006
- A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic StenosisNew England Journal of Medicine, 2005
- Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patientsNephrology Dialysis Transplantation, 2005
- Vascular Calcification MechanismsJournal of the American Society of Nephrology, 2004
- Vascular CalcificationJournal of the American Society of Nephrology, 2003
- Correlation of serum lipids, calcium and phosphorus, diabetes mellitus, aortic valve stenosis and history of systemic hypertension with presence or absence of mitral anular calcium in persons older than 62 years in a long-term health care facilityThe American Journal of Cardiology, 1987
- Noninvasive estimation of valve area in patients with aortic stenosis by Doppler ultrasound and two-dimensional echocardiography.Circulation, 1985
- Clinical characteristics of patients younger than 60 years with mitral anular calcium: Comparison with age- and sex-matched control subjectsThe American Journal of Cardiology, 1984